Antithrombotic Therapy clinical trials

Explore recruiting antithrombotic therapy clinical trials.

Recruiting antithrombotic therapy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Antithrombotic Therapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation

Spain, Austria, Czechia, Greece, Belgium, Italy +4 more

Therapeutic use (Phase IV) EU CTIS Study details

Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI)

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in non-atrial fibrillation patients after transcatheter aortic valve implantation: a pragmatic, international, multicentre, randomized clinical trial (POPular ATLANTIS trial)

Netherlands, France, Belgium, Denmark, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Monotherapy with a P2Y12 inhibitor followed by a direct-acting oral anticoagulant in patients with ATRial fIbrillation undergoing suprafleX Cruz coronary stent implantation (MATRIX-2)

Italy, Poland, Germany, France, Spain, Belgium +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and Safety of cangrelor on top of anticoagUlation in patients with myocaRdial infarction related cardiogenic shock/cardiac arrest receiVIng VA-ECMO and/or Impella support – a phase 2, single arm, single center trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Antithrombotic Therapy trials by city

Antithrombotic Therapy in Toronto Antithrombotic Therapy in Vancouver Antithrombotic Therapy in Montreal Antithrombotic Therapy in Calgary Antithrombotic Therapy in Edmonton Antithrombotic Therapy in Ottawa Antithrombotic Therapy in Winnipeg Antithrombotic Therapy in Quebec City Antithrombotic Therapy in Hamilton Antithrombotic Therapy in Kitchener Antithrombotic Therapy in London Antithrombotic Therapy in Halifax Antithrombotic Therapy in New York Antithrombotic Therapy in Los Angeles Antithrombotic Therapy in Chicago Antithrombotic Therapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease